Tagged With Coronavirus

Watch: Insider answers your questions about the risk of rare but serious blood clots following some COVID-19 vaccines

The FDA cited the vaccine plant that ruined millions of Johnson & Johnson doses for unsanitary conditions, finding 'brown residue' on the walls and peeling paint

Fake COVID-19 vaccines have been discovered by Pfizer in Mexico and Poland

Europe's top regulator weighs in on J&J's COVID-19 vaccine

Boris Johnson in lobbying scandal as leaked texts reveal he promised to 'fix' tax issue for James Dyson

Global stocks wobble as concerns of rising COVID-19 virus cases overshadow robust earnings

Biden's USDA says it will extend free school lunches for kids through spring 2022

How to manage your coronavirus vaccine side effects - including tips for avoiding painkillers

The billionaire scientist who developed Pfizer's breakthrough vaccine has not sold any shares in partner BioNTech's surging stock

A journalist in India live-tweeted his worsening COVID-19 symptoms, then died before he could get help

The EMA found a possible link between the Johnson & Johnson COVID-19 vaccine and 'unusual blood clots' and wants a warning attached

US stocks slump as global COVID-19 cases increase

It's pointless to wear a surgical mask over a fabric mask - the other way around is most effective, study finds

A vaccinated New Zealand airport worker tested positive for COVID-19 one day after the country opened a travel bubble with Australia

Global stocks pull back from record highs as COVID-19 cases rise at the fastest rate since the pandemic began

Moderna's mRNA technology could help in the decades-long search for an HIV vaccine

Arizona became the latest state to ban 'vaccine passports.' Its governor said the choice to get a shot or not is 'up to each individual.'

Trump is desperate to get credit for the COVID-19 vaccines, but his political heartlands are reluctant to actually take them

A record 5.2 million people globally tested positive for COVID-19 last week, despite the vaccine rollout ramping up in wealthy nations

Why Wall Street thinks Humana's undervalued